Showing results (41-50 of 116) with videos related to
Sort By:
Pageof 12
Pain Medicine (Malden, Mass.)|October 4, 2014
Comparative effects of morning vs. evening dosing of extended-release hydromorphone on sleep physiology in patients with low back pain: a pilot studyLynn R Webster, Michael D Smith, Sam Mackin, et al.Journal of Pain Research|November 26, 2015
Low-dose naloxone provides an abuse-deterrent effect to buprenorphineLynn R Webster, Michael D Smith, Cemal Unal, et al.Journal of Pain and Symptom Management|August 22, 2008
Long-term intrathecal ziconotide for chronic pain: an open-label studyLynn R Webster, Robert Fisher, Steven Charapata, et al.Current Medical Research and Opinion|January 26, 2018
Human abuse potential studies of abuse-deterrent opioids: lessons from oral and intranasal studies with morphine abuse-deterrent, extended-release, injection-molded tabletsLynn R Webster, Eugene R Viscusi, Colville Brown, et al.Journal of Pain Research|April 14, 2020
A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid TherapyLynn R Webster, Martin E Hale, Tadaaki Yamada, et al.Advances in Therapy|May 9, 2019
Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized StudyLynn R Webster, Eric R Kinzler, Carmela Pantaleon, et al.Postgraduate Medicine|September 10, 2011
Opioid titration and conversion in patients receiving morphine sulfate and naltrexone hydrochloride extended release capsulesLynn R Webster, Randall Brewer, David Morris, et al.The American Journal of Gastroenterology|April 29, 2015
A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer painM Mazen Jamal, Atoya B Adams, Jan-Peter Jansen, et al.Pain Medicine (Malden, Mass.)|March 28, 2008
Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic painLynn R Webster, Keri L Fakata, Steven Charapata, et al.Substance Abuse and Rehabilitation|January 30, 2014
Randomized, double-blind, placebo-controlled and active-controlled study to assess the relative abuse potential of oxycodone HCl-niacin tablets compared with oxycodone alone in nondependent, recreational opioid usersLynn R Webster, Robert L Rolleri, Glenn C Pixton, et al.Pageof 12